Aspect Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.94K Hold
23
– – ﹤0.01% 293
2026
Q2
$8.9K Hold
23
– – ﹤0.01% 304
2026
Q1
$6.73K Hold
23
– – ﹤0.01% 319
2025
Q4
$8.06K Buy
23
+3
+15% +$1.01K ﹤0.01% 306
2025
Q3
$6.46K Sell
20
-10
-33% -$3.11K ﹤0.01% 375
2025
Q2
$11.7K Hold
30
– – 0.01% 264
2025
Q1
$13K Hold
30
– – 0.01% 232
2024
Q4
$11.1K Sell
30
-1
-3% -$418 0.01% 267
2024
Q3
$16.1K Hold
31
– – 0.01% 215
2024
Q2
$16.8K Hold
31
– – 0.01% 206
2024
Q1
$16.1K Hold
31
– – 0.01% 210
2023
Q4
$14.6K Buy
+31
New +$14.3K 0.01% 206

Other funds holding ELV

Aspect Partners's ELV Position: Q3 2026 in Review

Aspect Partners held its Elevance Health (ELV) position steady in Q3 2026 at 23 shares worth $8.94K. The position accounts for ﹤0.01% of the portfolio, ranked #293.

Aspect Partners first reported a position in ELV in Q4 2023 and has held it in 12 quarters since. The position peaked at $16.8K in Q2 2024. 399 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Aspect Partners held 23 shares of Elevance Health worth $8.94K as of Q3 2026.
  • Aspect Partners left its Elevance Health share count unchanged in Q3 2026.
  • Elevance Health made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #293 holding.
  • Aspect Partners first reported a position in Elevance Health in Q4 2023 and has held it in 12 quarters since.
  • Aspect Partners's Elevance Health position peaked at $16.8K in Q2 2024.
  • 399 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.